1. Vertex CEO’s Pay Falls 38% to $17.4M in Second Straight Decline

    Vertex CEO’s Pay Falls 38% to $17.4M in Second Straight Decline

    Vertex Pharmaceuticals Inc. CEO Jeffrey M. Leiden saw his total compensation drop 38 percent to $17.4 million last year, largely on a steep cut in his stock-option awards from the Boston-based biotech. It was the second year in a row that Leiden’s pay declined from a 2014 payout of $36.6 million that made him the highest-paid head of a Massachusetts public company and sparked some shareholder criticism...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned

  3. Authors